Vanesa Agulló - Concepedia

Author

Vanesa Agulló

Universitat de Miguel Hernández d'Elx ORCID

Also Known As

V. Agulló, V.M. Gonzálvez Agulló, Vanesa Agulló, Vanessa Agulló, Victor Manuel Gonzálvez Agullo

Publications

725

Citations

H-Index

Concepts

All Affiliations

Universitat de Miguel Hernández d'Elx Hospital General Universitario de Elche Hospital Universitari Sant Joan D'Alacant Instituto de Salud Carlos III Generalitat Valenciana

About

Vanesa Agulló is an author at Universitat de Miguel Hernández d'Elx specializing in medicine, covid-19 epidemiology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	185
2	Public Health	2	2	30
3	Epidemiology	2	2	30
4	Immunology	2	2	172
5	Allergy	1	1	17

Vanesa Agulló

Publications

648

Citations

H-Index

Page 1

	Year	Citations
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study Javier García‐Abellán, Sergio Padilla, Marta Fernández‐González, Journal of Clinical Immunology Long CovidCovid-19 PandemicImmunologyLong-term Clinical OutcomeAntibody Response	2021	155
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study Mar Masiá, Marta Fernández‐González, Sergio Padilla, EBioMedicine	2020	78
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response Mar Masiá, Guillermo Telenti, Marta Fernández‐González, Open Forum Infectious Diseases	2021	69
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration Javier García‐Abellán, Marta Fernández‐González, Sergio Padilla, Frontiers in Immunology	2022	56
Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age Mar Masiá, Marta Fernández‐González, Manuel Sánchez-Molla, Open Forum Infectious Diseases	2021	52
Preemptive interleukin-6 blockade in patients with COVID-19 Lucía Guillén, Sergio Padilla, Marta Fernández‐González, Scientific Reports	2020	45
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination Marta Fernández‐González, Vanesa Agulló, Sergio Padilla, Clinical Infectious Diseases	2021	34
Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment Naïve Persons Starting INSTI-based Antiretroviral Therapy Ronald E. Galdamez, José Alberto García, Marta Fernández‐González, Open Forum Infectious Diseases	2019	33
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade Mar Masiá, Marta Fernández‐González, José Alberto García, EBioMedicine	2022	33
Performance of Saliva Specimens for the Molecular Detection of SARS-CoV-2 in the Community Setting: Does Sample Collection Method Matter? Marta Fernández‐González, Vanesa Agulló, Alba de la Rica, Journal of Clinical Microbiology	2021	28

Page 1